A UK TRT platform, in build. Looking for its founding clinical partner.

A working clinical operating system across four role-based portals. 57 dashboard pages, 103 API endpoints, 63 Prisma models. The Built today section above lists the visible surface; the architecture inventory in Compliance lists the regulated entities under append-only audit. Live demo by request, gated by an email reply so I can spend the time on serious enquiries.

Those are clinical services that built the minimum software they needed. TRT Platform is a clinical operating system that a clinical service can run on. Multi-tenant from day one, audit-ready by architecture, AI bounded to extraction and analysis with mandatory clinician PENDING_REVIEW. The category is platform, not vertically-integrated direct-to-consumer prescriber.

Because it cannot, lawfully or seriously, without a GMC-registered prescriber as the responsible person. The clinical signatory is the missing piece by design. CQC service registration, GPhC pharmacy partner, and the MHRA review at MVP all sit downstream of that decision. Recruiting the clinical lead is the page’s job.

Open to discuss. Equity-led, structure flexible. The right person can take this to full clinical co-founder with material equity, or sit at advisor-plus-signatory with proportionate equity. I would rather have the conversation than pre-fix the offer.

Range. From a focused advisor and signatory role (a few hours per month, named on regulatory submissions, reviewing the clinical surface at milestones) through full clinical co-founder (weekly clinical input on protocol, treatment plans, and the prescribing surface). Both shapes are real. The unlocked surface is the same either way.

Yes, by request. Email me with a sentence on who you are and what you would want to see, and I will send back a recorded walkthrough or set up a screen-share. The gate is intentional. It doubles as a serious-enquiry filter and lets me spend founder time on the right conversations.

Because the build phase is technical product work, and I am a technical product founder. AI-augmented is a build approach, not a credibility claim. Where a small team would have used contract specialists, I used Claude and Codex to compress the surface area. The launch phase is a clinical-regulatory problem, not a build problem, which is why a clinical co-founder is the natural next addition.